Centre de ressources virtuel des Rivières du Sud
  • Accueil
  • Collections
    • Collections de l'UASZ
    • Collections de Casadoc
    • Parcours Thématiques
  • Dépôts
  • En savoir plus
    • À propos
    • Actualités
    • Accueil
    • Collections
      • Collections de l'UASZ
      • Collections de Casadoc
      • Parcours Thématiques
    • Dépôts
    • En savoir plus
      • À propos
      • Actualités
    • Login
    View Item 
    •   DSpace Home
    • Université Assane Seck de Ziguinchor (UASZ)
    • UFR des Sciences de la Santé (2S)
    • Publications enseignants UFR 2S
    • View Item
    •   DSpace Home
    • Université Assane Seck de Ziguinchor (UASZ)
    • UFR des Sciences de la Santé (2S)
    • Publications enseignants UFR 2S
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of DSpaceCommunities & CollectionsTitlesAuthorsSubjectsBy Issue Datexmlui.ArtifactBrowser.Navigation.browse_territoireThis CollectionTitlesAuthorsSubjectsBy Issue Datexmlui.ArtifactBrowser.Navigation.browse_territoire

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contribution of an interferon gamma released assay to the detection of latent tuberculosis in chronic dialysis patients in sub-saharan africa

    Thumbnail
    View/Open
    P31 Quantiféron dialyse.pdf (776.8Kb)
    Date
    2019
    Author
    Lemrabott, Ahmed Tall
    Faye, Maria
    Faye, Moustapha
    Metadata
    Show full item record
    Abstract
    Introduction: Tuberculosis (TB) is common in patients with chronic renal failure due to their immunosuppressed state. Diagnosing TB is difficult because of the latency of the clinical and biological picture. This study was conducted to assess the performance of the Interferon Gamma Released Assay (IGRA) in the diagnosis of latent TB infection in chronic dialysis patients in Senegal. Materials and methods: This is a cross-sectional study carried out in Nephrology Department of Aristide Le Dantec University Hospital during 6 month. All patients with chronic haemodialysis or chronic peritoneal dialysis were included. A group of patients with non-dialyzed kidney disease was also included. Patients with active TB at the time of the study were not included. A tuberculin skin test (TST) and an IGRA were performed. The QuantiFERON® (QFT) was repeated 3 months later in the group of dialysis patients. Results: Sixty-two patients were included: 22 haemodialysis (HD) patients, 19 peritoneal dialysis (PD) patients and 21 patients with non-dialyzed kidney disease (NDKD). The mean age was 44 ± 12 years with a sex ratio M/F of 1.06. Nineteen patients were vaccinated with BCG. TST was positive in 22 patients (35.4%). Subjects with a positive TST had a significantly higher rate of BCG vaccination (P=0.002) than those with a negative TST. QFT was positive in 17 patients (28%) and undetermined in 9 patients (14%). In patients with a positive QFT, six (27%) were in HD, four (21%) in peritoneal dialysis and seven (33%) in NDKD. A total of 9/17 (52%) QFT-positive patients developed active TB. Correlation (r=0.998, p=0.001) indicates that T cell functionality was not affected by the duration of renal replacement therapy. Conclusion: These results highlight the advantage of Quantiferon test over TST for diagnosis of latent TB in immunocompromised patients, including chronic dialysis patients
    URI
    http://rivieresdusud.uasz.sn/xmlui/handle/123456789/493
    Collections
    • Publications enseignants UFR 2S

    Ce centre de ressources a été réalisé en partenariat avec et financé par:
    Contact Us | Send Feedback
     

    Ce centre de ressources a été réalisé en partenariat avec et financé par:
    Contact Us | Send Feedback